P L Amlot - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

P L Amlot

Showing results (51-60 of 56) with videos related to

Pageof 6

Sort By:

You have reached the last page of results.This site can display upto 56 results.

Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1996

Pharmacokinetics and immunodynamics of chimeric IL-2 receptor monoclonal antibody SDZ CHI 621 in renal allograft recipientsJ M Kovarik, E Rawlings, P Sweny, et al.

Transplantation Proceedings|April 1, 1996

Prolonged immunosuppressive effect and minimal immunogenicity from chimeric (CD25) monoclonal antibody SDZ CHI 621 in renal transplantationJ M Kovarik, E Rawlings, P Sweny, et al.

Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1993

Human mouse chimeric CD7 monoclonal antibody (SDZCHH380) for the prophylaxis of kidney transplant rejectionA I Lazarovits, J Rochon, L Banks, et al.

Transplantation Proceedings|February 1, 1993

Human mouse chimeric CD7 monoclonal antibody (SDZCHH380) for the prophylaxis of kidney transplant rejectionA I Lazarovits, J Rochon, L Banks, et al.

Hepatology (Baltimore, Md.)|October 26, 2000

Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanismsG J Webster, S Reignat, M K Maini, et al.

Gastroenterology|August 7, 2001

A randomized placebo-controlled trial of a humanized monoclonal antibody to alpha4 integrin in active Crohn's diseaseF H Gordon, C W Lai, M I Hamilton, et al.

Pageof 6

Search research articles

Showing results (51-60 of 56) with videos related to

Sort By:

Pageof 6

You have reached the last page of results.This site can display upto 56 results.

Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1996

Pharmacokinetics and immunodynamics of chimeric IL-2 receptor monoclonal antibody SDZ CHI 621 in renal allograft recipientsJ M Kovarik, E Rawlings, P Sweny, et al.

Transplantation Proceedings|April 1, 1996

Prolonged immunosuppressive effect and minimal immunogenicity from chimeric (CD25) monoclonal antibody SDZ CHI 621 in renal transplantationJ M Kovarik, E Rawlings, P Sweny, et al.

Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1993

Human mouse chimeric CD7 monoclonal antibody (SDZCHH380) for the prophylaxis of kidney transplant rejectionA I Lazarovits, J Rochon, L Banks, et al.

Transplantation Proceedings|February 1, 1993

Human mouse chimeric CD7 monoclonal antibody (SDZCHH380) for the prophylaxis of kidney transplant rejectionA I Lazarovits, J Rochon, L Banks, et al.

Hepatology (Baltimore, Md.)|October 26, 2000

Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanismsG J Webster, S Reignat, M K Maini, et al.

Gastroenterology|August 7, 2001

A randomized placebo-controlled trial of a humanized monoclonal antibody to alpha4 integrin in active Crohn's diseaseF H Gordon, C W Lai, M I Hamilton, et al.

Pageof 6